LNTH Lantheus Holdings, Inc.

company

SEC Filings & Insider Trading Activity 2026

Business Overview

• • Core business: Development, manufacturing, and commercialization of radiopharmaceutical and diagnostic imaging products
• • New launches: Acquisitions of Life Molecular (Neuraceq) and Evergreen, adding diagnostic imaging and CDMO services to portfolio in 2025
• • Strategic shifts: Discontinued AZEDRA in Q1 2024, sold TechneLite in 2026, focusing on higher-growth assets like Neuraceq and CDMO services
• • Notable metric: General & administrative expenses up $81.4M (42%) in 2025 due to acquisitions and litigation costs
• • Distinct fact: Paid $250M upfront for PNT2002 license but ceased development, deciding not to pursue NDA or further investment

Risk Factors

• • No specific or timely regulatory or legal risk detailed in the text
• • No concrete geopolitical or macroeconomic threat exposure disclosed
• • Operational risk from cybersecurity and data privacy requiring quarterly monitoring and oversight by Audit Committee
• • No named competitor or technology disrupting market environment mentioned
• • Key-person risk with CIO and CISO critical for risk management, each having ~30 years of industry experience

Management Discussion & Analysis

• • Operating cash flow $390.1M in 2025 vs $544.8M in 2024, decrease driven by acquisitions and working capital timing
• • Investing cash outflow $627.1M in 2025 vs $204.5M in 2024, 2025 includes $268.9M for Evergreen and $306.7M for Life Molecular acquisitions
• • Financing cash used $316.5M in 2025 vs $115.7M in 2024, due to $300M stock repurchase in 2025 vs $100M in 2024
• • No specific revenue or margin figures disclosed in this section
• • Management highlights increased credit facility to $750M with extended maturity to 2029, expects cash plus credit availability to cover needs next 12+ months

What are the latest LNTH SEC filings in 2026?

Lantheus Holdings, Inc. (LNTH) has filed a 10-K annual report on February 26, 2026, a 10-Q quarterly report on May 7, 2026, an 8-K current report on August 4, 2026 with the SEC. SignalX tracks every new SEC EDGAR filing daily, including 10-K, 10-Q, 8-K, and Form 4 insider transactions, with AI-powered summaries of key sections.

When did LNTH file its most recent 10-K annual report?

Lantheus Holdings, Inc. (LNTH) filed its most recent 10-K annual report on February 26, 2026. The 10-K includes audited financial statements, business overview, risk factors, and management discussion, all available on SignalX with AI-generated summaries and XBRL financial data.

How do I view LNTH 10-Q quarterly reports?

Lantheus Holdings, Inc. (LNTH)'s most recent 10-Q quarterly report was filed on May 7, 2026. SignalX displays every LNTH 10-Q with AI-generated summaries of the MD&A (Management Discussion & Analysis) and Risk Factors sections, plus links to the original SEC EDGAR document.

What 8-K current reports has LNTH filed recently?

Lantheus Holdings, Inc. (LNTH)'s most recent 8-K was filed on August 4, 2026. 8-K filings disclose material corporate events such as earnings releases, executive changes, mergers, and other significant developments. SignalX surfaces each 8-K with item-level summaries so you can quickly see what happened.

Where can I find LNTH insider trading activity (Form 4)?

SignalX aggregates every LNTH Form 4 insider transaction from SEC EDGAR. Form 4 reports show when officers, directors, and 10% shareholders buy or sell company stock, with transaction code, share count, and price per share.

How often does LNTH file with the SEC?

Lantheus Holdings, Inc. (LNTH) files a 10-K annual report once per year (typically within 60 days of fiscal year-end) and 10-Q quarterly reports three times per year. 8-K current reports are filed as needed when material events occur, and Form 4 insider transaction reports are due within two business days of a trade. SignalX monitors SEC EDGAR daily to surface every new LNTH filing with AI-powered analysis.

What is the difference between 10-K, 10-Q, and 8-K SEC filings?

A 10-K is a comprehensive annual report with audited financials, business overview, and risk factors. A 10-Q is a shorter quarterly report with unaudited financials and management discussion. An 8-K is a current report filed when a material event occurs, such as earnings releases, executive changes, acquisitions, or other significant developments. SignalX provides AI-generated summaries for all three filing types for Lantheus Holdings, Inc. (LNTH).

What is LNTH's SEC CIK number?

Lantheus Holdings, Inc. (LNTH)'s SEC CIK (Central Index Key) number is 1521036. The CIK is a unique identifier assigned by the SEC to every filing entity. You can use CIK 1521036 to look up all LNTH filings on SEC EDGAR, or browse them here on SignalX with AI-powered analysis.

Where can I find LNTH return on equity (ROE) and financial data?

SignalX extracts XBRL financial data from Lantheus Holdings, Inc. (LNTH) 10-K annual filings, including revenue, net income, gross profit, operating income, EPS, total assets, stockholders' equity, and operating cash flow. Return on equity (ROE) can be derived from net income divided by stockholders' equity. Multi-year financial trends are displayed in the Financial Summary table above.